| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/27/2011 | EP2314314A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
| 04/27/2011 | EP2314312A2 Peptides and therapeutic application therefof |
| 04/27/2011 | EP2314311A2 Peptides and therapeutic application thereof |
| 04/27/2011 | EP2314310A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 04/27/2011 | EP2314309A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 04/27/2011 | EP2313784A1 Immunotherapeutic method |
| 04/27/2011 | EP2313504A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 04/27/2011 | EP2313503A2 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 04/27/2011 | EP2313437A1 Cancerous disease modifying antibodies |
| 04/27/2011 | EP2313435A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 04/27/2011 | EP2313434A2 Antibodies that neutralize botulinum neurotoxins |
| 04/27/2011 | EP2313429A1 Msp-1 protein preparations from plasmodium |
| 04/27/2011 | EP2313427A2 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
| 04/27/2011 | EP2313390A1 Process for the preparation of nicotine-based haptens |
| 04/27/2011 | EP2313116A1 Improved bacterial polysaccharide-polypeptide conjugate compositions |
| 04/27/2011 | EP2313112A2 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 04/27/2011 | EP2313110A1 Effectors of par-2 activation and their use in the modulation of inflammation |
| 04/27/2011 | EP2313109A2 Il6 immunotherapeutics |
| 04/27/2011 | EP2313108A2 Malaria vaccine of self-assembling polypeptide nanoparticles |
| 04/27/2011 | EP2313097A2 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 04/27/2011 | EP2313095A2 Methods and products for treating proliferative diseases |
| 04/27/2011 | EP2313085A2 Immunogenic amphipathic peptide compositions |
| 04/27/2011 | EP1942985B1 Methods for reducing blood pressure |
| 04/27/2011 | EP1879598B1 Adjuvant comprising oligonucleotide and non toxic lps |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1578959B1 Immunizing fish against viral infection |
| 04/27/2011 | EP1539233B1 Super humanized antibodies |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1524994B1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 04/27/2011 | EP1432446B1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation |
| 04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
| 04/27/2011 | EP1368373B1 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
| 04/27/2011 | EP1272617B1 Prostate cell lines and their use |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | CN1893925B In vivo targeting of dendritic cells |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN102037136A Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of beta-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 04/27/2011 | CN102037015A Inhibition of angiogenesis |
| 04/27/2011 | CN102037011A Methods for treating psoriasis |
| 04/27/2011 | CN102036683A Cytotoxic composition |
| 04/27/2011 | CN102036682A Set of antiangiogenic molecules and use thereof |
| 04/27/2011 | CN102036681A Recombinant viral vectors and vaccine composition for leishmaniasis |
| 04/27/2011 | CN102036677A Heat shock protein GP96 vaccination and methods of using same |
| 04/27/2011 | CN102036660A Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 04/27/2011 | CN102031262A Construction method and application of faeG expressing gene engineering probiotic |
| 04/27/2011 | CN102030827A Anti-HER2 monoclonal antibody with high affinity |
| 04/27/2011 | CN102030826A High-affinity CD20-resistance monoclonal antibody |
| 04/27/2011 | CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN102028949A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 04/27/2011 | CN102028947A Inhibitor, inhibitor composition and inhibiting method of FAM3B gene, fatty liver treatment method and pharmaceutical application of inhibitor |
| 04/27/2011 | CN102028946A Taxus mairei immunological adjuvant and influenza vaccine containing same |
| 04/27/2011 | CN102028945A Spirulina polysaccharide immune adjuvant and influenza vaccine containing the same |
| 04/27/2011 | CN102028944A Combination vaccines with low dose of hib conjugate |
| 04/27/2011 | CN102028943A Respiratory syncytial virus-like particle vaccine and preparation method thereof |
| 04/27/2011 | CN102028942A Application of Escherichia coli in fish vaccine |
| 04/27/2011 | CN102028941A Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof |
| 04/27/2011 | CN102028940A Edwardsiella tarda surface display type vaccine and preparation and application thereof |
| 04/27/2011 | CN102028672A Microporous spongy film preparation and preparation method thereof |
| 04/27/2011 | CN101555483B Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof |
| 04/27/2011 | CN101306198B NR2B recombinant adenovirus vaccine |
| 04/27/2011 | CN101270155B Method for assembling foot and mouth disease virus hollow capsid in insect with acidproof improvement |
| 04/27/2011 | CN101081299B Yelk immune globulin products for preventing and treating bainite cryptosporidiosis and application thereof |
| 04/26/2011 | US7932430 Development of a simple animal model for infection by viruses and other obligate intracellular parasites |
| 04/26/2011 | US7932375 Kits for detecting rank nucleic acids |
| 04/26/2011 | US7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 04/26/2011 | US7932372 Antibodies to MAdCAM |
| 04/26/2011 | US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932360 Recombinant production of mixtures of antibodies |
| 04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 04/26/2011 | US7932351 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932229 Peptides for treatment of tumors/cancer |
| 04/26/2011 | US7932225 Glue composition for lung volume reduction |
| 04/26/2011 | US7932085 Modified leukotoxin gene and protein |
| 04/26/2011 | US7932074 Multivalent human-bovine rotavirus vaccine |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | US7931908 Chimeric MSP-based malaria vaccine |
| 04/26/2011 | US7931907 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same |
| 04/26/2011 | US7931906 Vero cell-based influenza virus strains and vaccines |
| 04/26/2011 | US7931905 Cynomolgus gp80 receptor and uses thereof |
| 04/26/2011 | US7931904 Modulation of MUC1 activity |
| 04/26/2011 | US7931903 Internalizing anti-CD74 antibodies and methods of use |
| 04/26/2011 | US7931902 Using transgenic animal models as tools in identifying and treating cell proliferative, cardiovascular, vision, muscular, nervous system, bone and metabolic disorders |
| 04/26/2011 | US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 04/26/2011 | US7931900 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity |
| 04/26/2011 | US7931899 Humanized anti-amyloid beta antibodies |
| 04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
| 04/26/2011 | US7931897 Therapeutic agent for hematopoietic tumors |
| 04/26/2011 | US7931896 Protein fusion for use as antagonist to V-set domain containing T cell activation inhibitor 1(B7 H4); treating rheumatoid atrhritis, cardiomyopathy, skin, liver and connective tissue disorders |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | US7931640 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 04/26/2011 | CA2501984C Erythropoietin receptor binding antibodies |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2416572C Bispecific antibody for target cell-specific stimulation of the apo-1 cell surface receptor |